… fianceETFs.com.
**Important Information About the Fund**
The Defiance 2X ANT Long Daily ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT) (the “Underlying Security” or “ANT”). Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds. It is also riskier than alternatives that do n …
Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
A
The
Fund seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the
share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT). The Fund does not seek to achieve its stated investment objective for a period other
than a single trading day.
**Fees
and Expenses of the Fund**
This
table describes the fees and expenses that you may pay if you buy, hold, and sell shares of the Fund (“Shares”). **You
may …
Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
A
… [email protected].
**Investment
Objective**
The
Fund’s primary investment objective is to seek current income. The Fund’s secondary investment objective is to seek exposure
to the share price of common stock of <strong>Anthropic, PBC</strong> (NASDAQ: ANT) (the “Underlying Security” or “ANT”), subject
in certain circumstances to a limit on the Fund’s participation in gains.
**Fees
and Expenses of the Fund**
This
table describes the fees and expenses that …
Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
A
… made by the Adviser’s investment committee and are not made by or delegated to AI tools. As of the date hereof, these tools
include enterprise generative artificial intelligence services, based on large language models, that are provided by third parties (currently
Google LLC (Gemini), OpenAI (ChatGPT) and <strong>Anthropic, PBC</strong> (Claude)), and are made available to the Adviser and its affiliates under enterprise
arrangements maintained by Rise Companies.
Fundrise Innovation Fund II, LLCAnthropic PBC·424B3 - Prospectus filing (Rule 424(b)(3))·Q3 27·13 Nov
A
… stitute notice):
Name:
Willkie Farr & Gallagher LLP
Address:
787 Seventh Avenue, New York, NY 10019-6099
Attn:
Russell Leaf; Sean M. Ewen
Email:
[email protected]; [email protected]
If
to the Investor, to:
Name:
<strong>Anthropic, PBC</strong>
Address:
548 Market Street, PMB 90375 San Francisco, CA 94104
Attn:
Email:
Email:
With
a copy to (which copy alone shall not constitute notice):
Name:
Davis Polk & Wardwell LLP
Address:
450 Lexington Avenu …
RUM Group Inc.Anthropic PBC·EX-4.1 - 10-Q - WARRANT AGREEMENT, DATED AS OF SEPTEMBER 30, 2026 Q3·Q3 26·12 Nov
A
… ology organizations. These include existing collaborations with Amgen, Inc. (“Amgen”), Novartis Pharma AG (“Novartis”), and Roswell Park Comprehensive Cancer Center (“Roswell Park”), as well as new collaborations with <strong>Anthropic, PBC</strong> to evaluate AI-enabled workflows in selected research programs using access to its life sciences researchers and frontier AI models; and new collaboration with Zealand Pharma A/S (“Zealand”) to design and develop mult …
Generate Biomedicines, Inc.Anthropic PBC·10-Q - Quarterly report Q3·Q3 26·12 Nov
… fianceETFs.com.
**Important Information About the Fund**
The Defiance 2X ANT Long Daily ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT) (the “Underlying Security” or “ANT”). Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds. It is also riskier than alternatives that do n …
Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
A
The
Fund seeks daily inverse investment results, before fees and expenses, of -2 times (-200%) the daily percentage change in the
share price of <strong>Anthropic, PBC</strong> (Nasdaq: ANT). The Fund does not seek to achieve its stated investment objective for a period other
than a single trading day.
**Fees
and Expenses of the Fund**
This
table describes the fees and expenses that you may pay if you buy, hold, and sell shares of the Fund (“Shares”). **You
may …
Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
A
… [email protected].
**Investment
Objective**
The
Fund’s primary investment objective is to seek current income. The Fund’s secondary investment objective is to seek exposure
to the share price of common stock of <strong>Anthropic, PBC</strong> (NASDAQ: ANT) (the “Underlying Security” or “ANT”), subject
in certain circumstances to a limit on the Fund’s participation in gains.
**Fees
and Expenses of the Fund**
This
table describes the fees and expenses that …
Tidal Trust IIAnthropic PBC·497K - Form 497K - SUMMARY PROSPECTUS·Q4 26·17 Nov
A
… made by the Adviser’s investment committee and are not made by or delegated to AI tools. As of the date hereof, these tools
include enterprise generative artificial intelligence services, based on large language models, that are provided by third parties (currently
Google LLC (Gemini), OpenAI (ChatGPT) and <strong>Anthropic, PBC</strong> (Claude)), and are made available to the Adviser and its affiliates under enterprise
arrangements maintained by Rise Companies.
Fundrise Innovation Fund II, LLCAnthropic PBC·424B3 - Prospectus filing (Rule 424(b)(3))·Q3 27·13 Nov
A
… stitute notice):
Name:
Willkie Farr & Gallagher LLP
Address:
787 Seventh Avenue, New York, NY 10019-6099
Attn:
Russell Leaf; Sean M. Ewen
Email:
[email protected]; [email protected]
If
to the Investor, to:
Name:
<strong>Anthropic, PBC</strong>
Address:
548 Market Street, PMB 90375 San Francisco, CA 94104
Attn:
Email:
Email:
With
a copy to (which copy alone shall not constitute notice):
Name:
Davis Polk & Wardwell LLP
Address:
450 Lexington Avenu …
RUM Group Inc.Anthropic PBC·EX-4.1 - 10-Q - WARRANT AGREEMENT, DATED AS OF SEPTEMBER 30, 2026 Q3·Q3 26·12 Nov
A
… ology organizations. These include existing collaborations with Amgen, Inc. (“Amgen”), Novartis Pharma AG (“Novartis”), and Roswell Park Comprehensive Cancer Center (“Roswell Park”), as well as new collaborations with <strong>Anthropic, PBC</strong> to evaluate AI-enabled workflows in selected research programs using access to its life sciences researchers and frontier AI models; and new collaboration with Zealand Pharma A/S (“Zealand”) to design and develop mult …
Generate Biomedicines, Inc.Anthropic PBC·10-Q - Quarterly report Q3·Q3 26·12 Nov